by extracapillary proliferation in> 50% of glomeruli. Clinically crescentic GN is characterized
by a nephritic syndrome rapidly progressing to end stage renal disease (ESRD). Three types
of crescentic GN have been identified. Type 1 includes cases of Goodpasture syndrome
characterized by linear deposits of antibodies along the glomerular basement membrane
(GBM) at immunofluorescence. Type 2 is a heterogeneous group of primary or secondary …